ArticleAdvances in therapy2020

Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States.

Jonathan K Kish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.